SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-011871
Filing Date
2024-03-29
Accepted
2024-03-29 08:00:36
Documents
13
Period of Report
2024-03-29
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43641
  Complete submission text file 0001493152-24-011871.txt   217488

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ensc-20240329.xsd EX-101.SCH 3012
3 XBRL LABEL FILE ensc-20240329_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE ensc-20240329_pre.xml EX-101.PRE 22357
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3672
Mailing Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037
Business Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037 (858) 263-4196
Ensysce Biosciences, Inc. (Filer) CIK: 0001716947 (see all company filings)

IRS No.: 822755287 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38306 | Film No.: 24802056
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)